ISOPRILINE isoprenaline hydrochloride 1.0 mg/5 mL injection solution ampoule

País: Austràlia

Idioma: anglès

Font: Department of Health (Therapeutic Goods Administration)

ingredients actius:

isoprenaline hydrochloride, Quantity: 1 mg

Disponible des:

Micro Labs Pty Ltd

formulario farmacéutico:

Injection, solution

Composición:

Excipient Ingredients: sodium hydroxide; water for injections; hydrochloric acid; sodium chloride; disodium edetate; sodium citrate dihydrate; citric acid

Vía de administración:

Intracardial, Intramuscular, Intravenous Bolus, Intravenous Infusion, Subcutaneous

Unidades en paquete:

10 ampoules

tipo de receta:

(S4) Prescription Only Medicine

indicaciones terapéuticas:

Isoprenaline Hydrochloride is indicated: For mild or transient episodes of heart block that do not require electric shock or pacemaker therapy.,For serious episodes of heart block and Adams-Stokes attacks (except when caused by ventricular tachycardia or fibrillation). (See Section 4.3 Contraindications),For use in cardiac arrest until electric shock or pacemaker therapy, the treatments of choice, are available. (See Section 4.3 Contraindications.),For bronchospasm occurring during anaesthesia.,As an adjunct to fluid and electrolyte replacement therapy and the use of other drugs and procedures in the treatment of hypovolaemic and septic shock, low cardiac output (hypoperfusion) states, congestive heart failure and cardiogenic shock. (See Section 4.4 Special warnings and precautions for use).

Resumen del producto:

Visual Identification: Clear, colorless to slightly yellow colour solution. Practically free from any visible particles.; Container Type: Ampoule; Container Material: Glass Type I Clear; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

Estat d'Autorització:

Registered

Data d'autorització:

2022-02-10